Vaseem Mahboob compensation by year
KESTRA MEDICAL TECHNOLOGIES Summary Compensation Table · all 3 fiscal years held| Component | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
| Salary | $397,515 | $427,828 | $470,000 |
| Bonus | $0 | $0 | $0 |
| Stock awards | $0 | $0 | $1,430,747 |
| Option awards | $0 | $1,648,830 | $0 |
| Non-equity incentive | $119,255 | $187,000 | $338,400 |
| Pension and deferred compensation | $0 | $0 | $0 |
| All other | $13,406 | $59,424 | $28,197 |
| Total | $530,176 | $2,323,082 | $2,267,344 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: KESTRA MEDICAL TECHNOLOGIES, LTD. DEF 14A filed July 28, 2026, accession 0001193125-26-320956, and prior-year filings. Open the filing on EDGAR.
How this page was built: the KESTRA MEDICAL TECHNOLOGIES, LTD. filed document, accession 0001193125-26-320956. Every figure is read from that document and cited to the page and table it appears in. Filed July 28, 2026.
Equity holdings
unvested awards at FY2026 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 44,118 | $914,125 | — |
| PSU | 22,059 | $457,062 | — |
| RSU | 22,059 | $457,062 | — |
| Option | 72,875 | — | $17.00 |
Per the Outstanding Equity Awards at Fiscal Year-End table in KESTRA MEDICAL TECHNOLOGIES, LTD.'s FY2026 proxy; value at the fiscal year-end close, as the company printed it.
KESTRA MEDICAL TECHNOLOGIES’s named executive officers, FY2026
as the company reported each| Named executive officer | Role | FY2026 total |
|---|---|---|
| Brian Webster | President, Chief Executive Officer & Director | $7,501,904 |
| Traci Umberger | General Counsel, Chief Administrative Officer & Director | $2,861,418 |
| Al Ford | Chief Commercial Officer | $2,792,086 |
| Vaseem Mahboob · this page | Chief Financial Officer | $2,267,344 |
The full KESTRA MEDICAL TECHNOLOGIES compensation record
free company briefThis page is one person within KESTRA MEDICAL TECHNOLOGIES's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the KESTRA MEDICAL TECHNOLOGIES proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order KESTRA MEDICAL TECHNOLOGIES's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are KESTRA MEDICAL TECHNOLOGIES's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order KMTS
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.